The European Commission will publish its review of the Covid-19 vaccine export licensing and transparency mechanism on Wednesday 24 March. It follows recent announcements by Commission President Ursula von der Leyen that AstraZeneca is not meeting its commitments on vaccine deliveries to the EU (see EUROPE B12683A24).
According to an EU source, the review will follow the direction of the President’s speech on the need for reciprocity with countries that receive vaccines produced in the...